Nutritional Treatment of Patients with Colorectal Cancer.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
04 06 2022
Historique:
received: 09 05 2022
revised: 02 06 2022
accepted: 02 06 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

Colorectal cancer is one of the most common cancers in Europe and the world. Cancer treatments have side effects and cause significant deterioration of the patient's nutritional status. Patient malnutrition may worsen the health condition and prevent the deliberate effects of the therapy. The aim of this review was to describe the available data about clinical nutrition in colorectal cancer patients. A large proportion of colorectal cancer patients suffer from malnutrition, which negatively affects the survival prognosis, quality of life, and oncological therapy. Therefore, monitoring nutritional status during the treatment is essential and can be used to arrange proper nutritional therapy to enhance patient responses, prevent side effects, and shorten recovery time. The principles of nutrition during anticancer therapy should mainly consider light and low-fat foods, the exclusion of lactose and gluten-containing foods in certain cases, or the introduction of special dietary products such as oral nutrition supplements and it should be tailored to patients' individual needs.

Identifiants

pubmed: 35682464
pii: ijerph19116881
doi: 10.3390/ijerph19116881
pmc: PMC9180662
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):437-446
pubmed: 28052576
Cell Mol Life Sci. 2017 Aug;74(16):2959-2977
pubmed: 28352996
Nutrition. 2020 Jul - Aug;75-76:110769
pubmed: 32272362
CA Cancer J Clin. 2015 Nov-Dec;65(6):428-55
pubmed: 26348643
Adv Nutr. 2014 Sep 15;5(5):624S-633S
pubmed: 25225347
Nutrients. 2017 Sep 15;9(9):
pubmed: 28914794
Proc Nutr Soc. 2015 Aug;74(3):227-34
pubmed: 25518735
J Clin Oncol. 2015 Nov 1;33(31):3598-607
pubmed: 26282659
Clin Nutr. 2017 Feb;36(1):49-64
pubmed: 27642056
J Neurogastroenterol Motil. 2021 Jan 30;27(1):19-34
pubmed: 33166939
Acta Haematol. 2019;142(1):21-29
pubmed: 30970362
Ann Oncol. 2017 Jun 01;28(6):1359-1367
pubmed: 28327908
Indian J Surg Oncol. 2017 Dec;8(4):457-461
pubmed: 29203973
Oncotarget. 2017 Aug 10;8(45):79884-79896
pubmed: 29108370
Curr Pharm Des. 2016;22(15):2270-8
pubmed: 26891806
Cochrane Database Syst Rev. 2015 Dec 23;(12):CD011552
pubmed: 26695736
Ann Surg Oncol. 2019 Jul;26(7):2037-2043
pubmed: 30949861
Clin Nutr ESPEN. 2020 Dec;40:1-6
pubmed: 33183519
Genome Med. 2016 Apr 20;8(1):42
pubmed: 27098727
Nutrients. 2022 Jan 14;14(2):
pubmed: 35057525
Biomed Res Int. 2015;2015:428169
pubmed: 26075239
Nutrients. 2019 May 22;11(5):
pubmed: 31121926
Nat Rev Dis Primers. 2018 Jan 18;4:17105
pubmed: 29345251
Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):470-9
pubmed: 24686268
Hormones (Athens). 2020 Mar;19(1):41-46
pubmed: 31273668
Rev Endocr Metab Disord. 2014 Sep;15(3):189-96
pubmed: 24789701
Proc Nutr Soc. 2016 May;75(2):199-211
pubmed: 26786393
Front Nutr. 2021 Apr 07;8:603936
pubmed: 33898493
Gastroenterol Clin North Am. 2018 Mar;47(1):231-242
pubmed: 29413016
Clin Nutr. 2021 Jan;40(1):47-53
pubmed: 32563599
JAMA Oncol. 2018 Jan 01;4(1):71-79
pubmed: 29098294
Nutrients. 2019 Nov 07;11(11):
pubmed: 31703257
Clin Nutr. 2021 May;40(5):2898-2913
pubmed: 33946039
J Urol. 2019 Mar;201(3):470-477
pubmed: 30359680
J Clin Oncol. 2022 Mar 1;40(7):740-751
pubmed: 34995084
Nutrition. 2019 Nov - Dec;67-68:110550
pubmed: 31525608
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Nutrients. 2016 Mar 12;8(3):163
pubmed: 26985904
JPEN J Parenter Enteral Nutr. 2019 Aug;43(6):794-802
pubmed: 30565718
Gastroenterology. 2018 Mar;154(4):916-926.e9
pubmed: 29158191
Semin Oncol Nurs. 2015 Feb;31(1):42-52
pubmed: 25636394
Antibodies (Basel). 2022 Feb 25;11(1):
pubmed: 35323191
Br J Cancer. 2018 Oct;119(7):785-792
pubmed: 30287914

Auteurs

Agata Lewandowska (A)

Nutritional Treatment Clinic, Institute of Hematology and Transfusion Medicine, 00-791 Warsaw, Poland.

Urszula Religioni (U)

School of Public Health, Center of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland.

Aleksandra Czerw (A)

Department of Health Economics and Medical Law, Medical University of Warsaw, 02-091 Warsaw, Poland.
Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.

Andrzej Deptała (A)

Department of Cancer Prevention, Medical University of Warsaw, 02-091 Warsaw, Poland.

Beata Karakiewicz (B)

Subdepartment of Social Medicine and Public Health, Department of Social Medicine, Pomeranian Medical University in Szczecin, 70-103 Szczecin, Poland.

Olga Partyka (O)

Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.

Monika Pajewska (M)

Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.

Katarzyna Sygit (K)

Faculty of Health Sciences, Calisia University, 62-800 Kalisz, Poland.

Elżbieta Cipora (E)

Faculty of Medical Science, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.

Kamila Kmieć (K)

Faculty of Health Sciences, Calisia University, 62-800 Kalisz, Poland.

Anna Augustynowicz (A)

School of Public Health, Center of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland.
Department of Health Economics and Medical Law, Medical University of Warsaw, 02-091 Warsaw, Poland.

Dominika Mękal (D)

Department of Cancer Prevention, Medical University of Warsaw, 02-091 Warsaw, Poland.

Michał Waszkiewicz (M)

School of Public Health, Center of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland.

Agnieszka Barańska (A)

Department of Medical Informatics and Statistics with E-Learning Lab, Medical University of Lublin, 20-090 Lublin, Poland.

Daniela Mináriková (D)

Faculty of Pharmacy, Comenius University in Bratislava, 814 99 Bratislava, Slovakia.
Institute for Prevention and Intervention, St. Elizabeth University of Health and Social Work, 811 02 Bratisla-va, Slovakia.

Peter Minárik (P)

Institute for Prevention and Intervention, St. Elizabeth University of Health and Social Work, 811 02 Bratisla-va, Slovakia.
Biomedical Research Center of the Slovak Academy of Sciences, 845 04 Bratislava, Slovakia.

Piotr Merks (P)

Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardi-nal Stefan Wyszyński University, 01-815 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH